GTC Biotherapeutics (fka GTCB)

[DewDiligence]

>I assume that the poison pill provides management with huge stock voting shares to stop the takeover…<

The poison pill provides all shareholders except the prospective acquirer with additional shares, diluting the prospective acquirer’s equity stake to the point where a hostile takeover becomes untenable.

Moreover, a lot of the value of GTC is tied up in its know-how and human capital, and any company attempting a hostile takeover would be risking the loss of these assets.

In short, a hostile takeover is way, way down on my list of concerns as a GTC shareholder. It’s so far down on the list I don’t think it’s worth talking about unless someone like you brings it up.